ALFA-AMYLASE BGR CONSEIL 3000 U.CEIP, coated tablet 24 tablets
Active ingredients: ALFA-AMYLASE
Commercialized according to BDPM
Coated tablet24 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALFA-AMYLASE BGR CONSEIL 3000 U.CEIP, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- 2 plaquette(s) thermoformée(s) PVC PVDC aluminium de 12 comprimé(s)
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Jan 2023
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63232204CIP73500370CIP133400935003706Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALFA-AMYLASEcomprimé | 3000 unités CEIP · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.